Search hospitals > California > Santa Barbara
Sansum Diabetes Research Institute
Claim this profileSanta Barbara, California 93105
Global Leader in Diabetes
Global Leader in Type 1 Diabetes
Conducts research for Type 2 Diabetes
Conducts research for Metabolic Diseases
Conducts research for Gestational Diabetes
82 reported clinical trials
5 medical researchers
Summary
Sansum Diabetes Research Institute is a medical facility located in Santa Barbara, California. This center is recognized for care of Diabetes, Type 1 Diabetes, Type 2 Diabetes, Metabolic Diseases, Gestational Diabetes and other specialties. Sansum Diabetes Research Institute is involved with conducting 82 clinical trials across 28 conditions. There are 5 research doctors associated with this hospital, such as Kristin Castorino, David Kerr, MD, Raul Bastarrachea, MD, and Ashley Thorsell, MD.Top PIs
Kristin CastorinoSansum Diabetes Research Institute1 year of reported clinical research
Studies Diabetes
Studies Type 2 Diabetes
10 reported clinical trials
19 drugs studied
David Kerr, MDSansum Diabetes Research Institute2 years of reported clinical research
Studies Type 2 Diabetes
Studies Diabetes
4 reported clinical trials
7 drugs studied
Raul Bastarrachea, MDSansum Diabetes Research Institute1 year of reported clinical research
Studies Diabetes
Studies Type 2 Diabetes
2 reported clinical trials
2 drugs studied
Ashley Thorsell, MDSansum Diabetes Research Institute1 year of reported clinical research
Studies Type 2 Diabetes
Studies Mental Health Issue
2 reported clinical trials
2 drugs studied
Clinical Trials running at Sansum Diabetes Research Institute
Diabetes
Type 2 Diabetes
Type 1 Diabetes
Gestational Diabetes
Nutrition-Lifestyle Therapy
for Gestational Diabetes
Socioeconomically disadvantaged (SED) pregnant Latina women are disproportionately burdened by type 2 diabetes (T2D). Although lifestyle interventions can help to improve diabetes control, there are barriers to SED, Spanish-speaking pregnant people participating. The purpose of this proposal is to develop and test a culturally tailored, dietary-lifestyle behavioral intervention that supports eating plant-based foods such as fruits, vegetables, nuts and grains instead of processed foods and meat, and is implemented through community health workers (CHWs) to prevent excessive weight gain during pregnancy and improve control of blood sugar levels in pregnant Latina women with T2D. This study takes advantage of our existing strong relationships with the local Latino community, CHWs, and Santa Barbara County Public Health, which includes eight multidisciplinary healthcare clinics with sliding fee programs, and Rooted Santa Barbara, a community plant-based lifestyle organization. Cultural sensitivity focuses on delivering health information based on norms, values, beliefs, environmental factors, and historical context that is unique to a racial/ethnic population. Therefore, for our program to be culturally sensitive, it will include delivery of the program by CHWs primarily in the Spanish language with English as needed and incorporation of culturally relevant eating and physical activity recommendations. The specific aims of the project are: 1) in year one, develop the dietary-lifestyle behavioral intervention that encourages a plant-forward diet for pregnant Latina women with T2D to prevent excessive weight gain during pregnancy and improve blood sugar control in collaboration with CHWs and participants by conducting focus groups to incorporate feedback on the program; 2) initiate in year one, and in year two, conduct a randomized controlled trial with 30 pregnant Latina women with T2D to evaluate the how well the nutrition-behavior lifestyle program works; and 3) evaluate the acceptance and delivery of the dietary-lifestyle behavioral intervention in CHWs and participants. If successful, this study will establish the how well a culturally sensitive program delivered by CHWs incorporating plant-forward diets for pregnant Latina women with T2D prevents excessive weight gain during pregnancy, and control of blood sugar levels.
Recruiting1 award N/A
MiniMed™ 780G System
for Type 2 Diabetes
This trial is testing the MiniMed™ 780G system, which includes an insulin pump and sensors, in adults aged 18-80 with type 2 diabetes who need insulin. The device continuously checks blood sugar levels and automatically adjusts insulin delivery to keep blood sugar stable. The study will last several months and involve up to 575 participants across the United States. The MiniMed™ 780G system is an advanced hybrid closed-loop system that has been previously tested in various populations, including adolescents and adults with type 1 diabetes, showing improvements in blood sugar control.
Recruiting1 award N/A3 criteria
Hybrid Closed Loop System
for Type 1 Diabetes
The purpose of this study is to evaluate the safety and effectiveness of the Hybrid Closed Loop system (HCL) in adult and pediatric patients with type 1 diabetes in the home setting. A diverse population of patients with type 1 diabetes will be studied. The study population will have a large range for duration of diabetes and glycemic control, as measured by glycosylated hemoglobin (A1C). They will be enrolled in the study regardless of their prior diabetes regimen, including using Multiple Daily Injections (MDI), Continuous Subcutaneous Insulin Infusion (CSII) or Sensor-Augmented Pump therapy (SAP)
Recruiting1 award N/A17 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Sansum Diabetes Research Institute?
Sansum Diabetes Research Institute is a medical facility located in Santa Barbara, California. This center is recognized for care of Diabetes, Type 1 Diabetes, Type 2 Diabetes, Metabolic Diseases, Gestational Diabetes and other specialties. Sansum Diabetes Research Institute is involved with conducting 82 clinical trials across 28 conditions. There are 5 research doctors associated with this hospital, such as Kristin Castorino, David Kerr, MD, Raul Bastarrachea, MD, and Ashley Thorsell, MD.